Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM
Fraunhofer research consortium iCAIR® uses synergies to develop new medications against SARS-CoV-2
Hannover, Deutschland (ots/PRNewswire) - The new coronavirus SARS-CoV-2 has triggered a public health emergency of international concern. To date, there is neither a vaccine nor drugs for COVID-19 treatment available. Researchers of the international consortium https://www.item.fraunhofer.de/en/lighthouse-projects/icair-project.html are striving to develop novel ...
plus